Clinical Trials Browser

Phase 1/2 × navitoclax × Thoracic × Clear all

NCT03366103 2023-10-17

Navitoclax and Vistusertib in Treating Patients With Relapsed Small Cell Lung Cancer and Other Solid Tumors

Phase 1/2 Terminated

15 enrolled 14 charts

Neoplasm Metastasis, Small Cell Lung Carcinoma

NCT00445198 2018-06-06

A Phase 1/2a Study of ABT-263 in Subjects With Small Cell Lung Cancer (SCLC) or Other Non-Hematological Malignancies

Phase 1/2 Completed

Small Cell Lung Carcinoma